Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CuI Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107311862A reveals a cost-effective Grignard route for sitagliptin intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Novel CuI catalytic method for 2-oxazolidinone intermediates. Reduces energy costs and enables scalable pharmaceutical manufacturing under ambient conditions.
Novel CuI-catalyzed synthesis of pyridine compounds from oximes and ethyl pyruvate. Mild conditions, wide substrate scope, ideal for API intermediates.
Patent CN107501237B reveals a cyanide-free Apalutamide synthesis. Enhance supply chain safety and reduce manufacturing costs with this novel pharmaceutical intermediate route.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Patent CN110015981B details a CuI-catalyzed three-component synthesis of functionalized thioethers. This method offers mild conditions, high yields, and significant cost reduction in pharmaceutical manufacturing.